BridgeBio Oncology Therapeutics, Inc. (BBOT) Stock buybacks
BridgeBio Oncology Therapeutics, Inc. (BBOT) annual stock buyback history — cash paid to repurchase common stock, per SEC filings.
No annual history for this metric yet
The company may have no SEC filings (ETF / non-US listing), or the concept is absent from its filings.
← Back to BBOTSource: SEC XBRL filings · For reference only · Not investment advice
More BBOT financial trends
BBOT RevenueBBOT Net incomeBBOT Net marginBBOT Gross profitBBOT Gross marginBBOT Operating incomeBBOT Operating marginBBOT Operating cash flowBBOT Free cash flowBBOT Capital expendituresBBOT Return on equityBBOT Dividends paidBBOT Total assetsBBOT Total liabilitiesBBOT Shareholders’ equityBBOT overview →